What to watch with MTHFR and menopause?

When considering MTHFR variants (e.g., C677T or A1298C) during menopause, the key focus should be on homocysteine metabolism and cardiovascular risk, not on exaggerated claims. MTHFR is involved in folate cycling; reduced activity can raise homocysteine, a risk factor for heart disease, which increases after menopause. Some observational studies link MTHFR polymorphisms to menopausal symptoms like hot flashes or mood changes, but effect sizes are small and inconsistent. There is no robust evidence that MTHFR variants directly cause severe menopausal issues or that high-dose folic acid or methylfolate supplementation is beneficial without documented deficiency or elevated homocysteine. In fact, excessive folic acid (>1 mg/day) can mask vitamin B12 deficiency, which is more common in older adults. Practical advice: measure serum homocysteine, vitamin B12, and folate before any supplementation. Focus on a diet rich in natural folates (leafy greens, legumes), maintain physical activity, and manage stress. Discuss with a healthcare provider to assess overall cardiovascular risk, bone health, and hormone therapy options. Consumer DNA tests often overstate MTHFR’s role; the evidence for gene–menopause interactions is mixed at best. Do not self-prescribe high-dose B vitamins based on genetics alone.